Parkinson's Disease and Movement Disorders Center, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, 330 S. 9th st, Philadelphia, PA 19107, USA.
Division of Movement Disorders, Department of Neurology, University of Alabama at Birmingham, Birmingham, AL, USA.
Sleep Med Rev. 2017 Oct;35:33-50. doi: 10.1016/j.smrv.2016.08.001. Epub 2016 Aug 31.
Sleep disorders are among the most common non-motor manifestations in Parkinson's disease (PD) and have a significant negative impact on quality of life. While sleep disorders in PD share most characteristics with those that occur in the general population, there are several considerations specific to this patient population regarding diagnosis, management, and implications. The available research on these disorders is expanding rapidly, but many questions remain unanswered. We thus conducted a systematic review of the literature published from 2005 to 2015 on the following disorders of sleep and wakefulness in PD: REM sleep behavior disorder, insomnia, nocturia, restless legs syndrome and periodic limb movements, sleep disordered breathing, excessive daytime sleepiness, and circadian rhythm disorders. We discuss the epidemiology, etiology, clinical implications, associated features, evaluation measures, and management of these disorders. The influence on sleep of medications used in the treatment of motor and non-motor symptoms of PD is detailed. Additionally, we suggest areas in need of further research.
睡眠障碍是帕金森病(PD)中最常见的非运动症状之一,对生活质量有重大负面影响。虽然 PD 中的睡眠障碍与一般人群中发生的睡眠障碍具有大多数共同特征,但针对该患者人群,在诊断、管理和影响方面存在一些需要考虑的特殊因素。关于这些障碍的现有研究正在迅速扩展,但仍有许多问题尚未得到解答。因此,我们对 2005 年至 2015 年间发表的关于 PD 中以下睡眠和清醒障碍的文献进行了系统综述:快速眼动睡眠行为障碍、失眠、夜尿症、不宁腿综合征和周期性肢体运动、睡眠呼吸障碍、日间嗜睡过多和昼夜节律障碍。我们讨论了这些障碍的流行病学、病因、临床意义、相关特征、评估措施和管理。详细说明了用于治疗 PD 的运动和非运动症状的药物对睡眠的影响。此外,我们还提出了需要进一步研究的领域。